Philips initiated a voluntary recall for some of its sleep apnea machines and ventilators. The American multinational conglomerate company cited concerns for a foam component that may get detached or degrade and become toxic when inhaled by the user.
It was said that if such a thing happens, there is a possibility it could cause health issues including the development of cancer due to toxic and carcinogenic effects. To prevent this and protect the users, Philips issued a recall notification on Monday, June 14.
The affected devices and Philips’ announcement
As per Fox Business, the Philips recall will affect three to four million units of certain machine models that feature Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAC) and the mechanical ventilator machines. It was revealed that the company already issued the first warning over the issue in April.
Philips announced its voluntary recall notification after consulting with regulatory agencies. The company said that with the recalled products, the company will immediately take corrective actions that include the distribution of updated instructions for the repair and replacement of the affected items. As of this time, Philips is continuously monitoring reports of safety issues and so far, it has not received any reports of death due to the product issues.
It was added that due to potential risks of exposure, users may experience headaches, respiratory issues, irritation, inflammation and possible toxic or carcinogenic effects. But fortunately, there is no report of these effects yet related to chemical emissions.
“We deeply regret any concern and inconvenience that patients using the affected devices will experience because of the proactive measures we are announcing today to ensure patient safety,” Philips CEO, Frans van Houten, said in a press release. “In consultation with the relevant regulatory agencies and in close collaboration with our customers and partners, we are working hard towards a resolution. Patient safety is at the heart of everything we do at Philips.”
How Philips will solve the issue
Reuters reported that Philips is now working with the health authorities and regulators for the safety of the consumers. It is looking for a way for the safe replacement of the foam that may potentially become toxic and cause cancer.
It was added that Philips is not conducting tests and it needs to get good results so it can pass the regulatory requirements. The company will also be replacing the products that cannot be repaired or updated.


Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
Innate Pharma Reports 55% Revenue Drop and €49.2M Net Loss for 2025
Google's TurboQuant Algorithm Sends Memory Chip Stocks Tumbling
Iran-Israel Missile Strikes Continue Amid Mixed Signals on U.S.-Iran Diplomacy
Federal Reserve Balance Sheet Reduction: Brookings Research Outlines Possible Path Forward
Oil Prices Climb as Iran Reviews U.S. Peace Proposal Amid Middle East Tensions
SMIC Allegedly Supplies Chipmaking Tools to Iran's Military, U.S. Officials Warn
Japan Eyes Oil Futures Intervention to Stabilize Yen Amid Middle East Crisis
Meta Ties Executive Pay to Aggressive Stock Price Targets in Major Retention Push
Air Canada Express Crash at LaGuardia: Controller Distracted by Prior Emergency
Henkel in Advanced Talks to Acquire Olaplex at $2 Per Share
Gold Prices Drop Amid Iran Peace Talk Uncertainty and Stronger Dollar
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
U.S. Stocks Tumble as Iran Peace Deal Uncertainty Spooks Markets
Bank of Japan Officials Signal Continued Interest Rate Hikes Amid Inflation Concerns
Nintendo Switch 2 Production Cut as Holiday Sales Miss Targets 



